ACCURADX

Owners

Goods & Services

genetics, genomics and epigenomics-related reagents for medical diagnostic purposes via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs)

Downloadable computer software for bioinformatics analyses of NGS data for research use only and medical diagnostic purposes via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs)

genetics, genomics and epigenomics-related reagents for research use, including for nucleic acid and protein sample preparation for next-generation sequencing (NGS)

Scientific research, scientific analytical research and scientific research consulting services in the field of next-generation sequencing (NGS) and sample preparation therefor, performance for NGS, DNA and RNA mapping technologies including KAS-seq, Keth-seq, CAP-C, and assisting researchers using of NGS technologies; scientific research services regarding DNA and RNA mapping technologies including KAS-seq, Keth-seq, CAP-C; scientific research consulting services in the field of assisting researchers using of NGS technologies; scientific research, scientific analytical research and scientific research consulting services in the field of medical diagnoses via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs); software as a service (SAAS) services featuring analytic software platforms focusing on bioinformatics analyses of NGS data for research use only and future medical diagnostic purposes via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs)